ReviewClinical ophthalmology (Auckland, N.Z.)2026
Comparative Clinical and Therapeutic Landscape of Aflibercept Biosimilars (YESAFILI), High-Dose Aflibercept 8 mg (EYLEA HD), and Faricimab (VABYSMO): A Structured Narrative Review.
Carmen BalianPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.